Tech Company Financing Transactions
Remission Medical Funding Round
Blue Heron Capital and private investors joined a Series A venture round for Remission Medical. The financing round was announced on 4/13/2026.
Transaction Overview
Company Name
Announced On
4/13/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Blue Heron Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds to further enhance the expansion of its partner network, grow its clinical workforce, and accelerate the scaling infrastructure
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1010 Borden Road
Richmond, VA 23229
USA
Richmond, VA 23229
USA
Phone
Undisclosed
Website
Email Address
Overview
Our mission is to provide relief from pain caused by autoimmune and inflammatory conditions by expanding access to high-quality rheumatology care. We do this by partnering with health systems and specialty practices, supported by a virtual workforce of vetted, board-certified rheumatology providers. Access to rheumatology care is one of the most persistent challenges in modern healthcare. Patients often wait months for evaluation, delaying diagnosis, treatment, and long-term outcomes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Blake Wehman
Chief Medical Officer
Kyle Harner
Chief Operating Officer
Bhavika Amin
Chief Technical Officer
Tyler Beard
VP - Bus. Development
Matt Hogan
VP - Bus. Development
Michael Spine
VP - Sales
Blake Siewert
Browse more venture capital transactions:
Prev: 4/13/2026: Replenit venture capital transaction
Next: 4/13/2026: Citra Space venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs